Loading clinical trials...
Loading clinical trials...
An Open Label, Single Arm, Multicenter Study to Evaluate the Effect of Voxelotor on Cerebral Blood Flow and Neurocognitive Function in Adolescents and Adults With Sickle Cell Disease
Conditions
Interventions
Voxelotor Oral Tablet
Locations
2
United States
Washington University School of Medicine
St Louis, Missouri, United States
The Children's Hospital at Montefiore
The Bronx, New York, United States
Start Date
August 9, 2023
Primary Completion Date
August 23, 2023
Completion Date
August 23, 2023
Last Updated
August 9, 2024
NCT05170412
NCT06526117
NCT06665997
NCT07431398
NCT07222475
NCT05377372
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions